Batten disease, also known as neuronal ceroid lipofuscinoses (NCLs), encompasses a collection of neurodegenerative disorders characterized by lysosomal storage dysfunction. The impaired functioning of the lysosome, caused by a genetic mutation, triggers the accumulation of substances within the cell. Batten disease can arise from mutations in any of the 13 identified genes, and while specific symptoms may vary depending on the affected gene, there are commonalities among them.
Disease Process: Understanding the Mechanism of Batten Disease
Batten disease is characterized by gene mutations that impede the normal functioning of cellular lysosomes. These mutations hinder the breakdown of crucial molecules such as proteins, carbohydrates, and old cell parts. As a result, a cascade of complications arises, although the severity of symptoms and their onset may differ among individuals. Initially, Batten disease was associated with a specific subset of NCLs (neuronal ceroid lipofuscinoses), but its definition has expanded to encompass all forms of this disorder.
Progression
Batten disease typically manifests its symptoms during childhood, although the age of onset can differ depending on the specific genetic mutation involved. Initially, individuals may experience behavioral changes, difficulties with learning, and sluggish or involuntary movements. As time passes, these symptoms worsen and may lead to seizures, as well as the gradual loss of language, motor skills, and intellectual capabilities. Ultimately, children affected by Batten disease will experience a complete decline in cognitive function and the ability to perform basic motor tasks.